Jl. Kurtzman et al., DO NIFEDIPINE AND VERAPAMIL POTENTIATE THE CARDIAC TOXICITY OF MAGNESIUM-SULFATE, American journal of perinatology, 10(6), 1993, pp. 450-452
We hypothesized that verapamil and nifedipine would potentiate the car
diac toxicity of magnesium in a dose-dependent manner. The hypothesis
was tested in the isolated perfused rat heart model (Langendorff's app
aratus) with Sprague-Dawley rats. After excision of hearts, each heart
was exposed to increasing doses of verapamil and nifedipine followed
by magnesium sulfate. Heart rate, contractility, and left ventricular
systolic pressure were measured. Nifedipine and verapamil infusion in
this model caused dose-dependent decreases in all three parameters mea
sured (p values 0.05 to 0.01). The addition of magnesium sulfate poten
tiated these dose-dependent decreases (p values 0.01 to 0.0002). Nifed
ipine and verapamil caused similar depression at equivalent doses. Nif
edipine and verapamil cause dose-dependent cardiac depression that is
potentiated by the addition of magnesium sulfate in the isolated perfu
sed rat heart. Caution is called for when magnesium sulfate and calciu
m channel blockers are administered in combination.